ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일
Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma
Diffuse Large B-cell-lymphoma; DLBCL, Nos Genetic Subtypes · CD19
Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα
CD30-Positive Diffuse Large B-Cell Lymphoma; Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type · CD30
Hematological Malignancies · Hematological Malignancies
Relapsed or Refractory Plasma Cell Neoplasms · BCMA
High-risk Plasma Cell Neoplasms · BCMA
Lupus Erythematosus, Systemic; System; Sclerosis · Lupus Erythematosus, Systemic
System Lupus Erythematosus(SLE) · System Lupus Erythematosus(SLE)
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma; Relapsed/Refractory B-cell ALL · FRα
Large B-cell Lymphoma; B-cell Lymphoma · Large B-cell Lymphoma
Adverse Drug Reactions; Cancer · Adverse Drug Reactions
Hematologic Malignancy; Leukemia · Hematologic Malignancy
Multiple Myeloma; Relapse Multiple Myeloma · BCMA
B Cell Lymphoma; B Cell Leukemia · BCMA
B Cell Lymphoma; B Cell Leukemia · CD19
B Cell Lymphoma; B Cell Leukemia · B Cell Lymphoma
Advanced Solid Tumor · CLDN18.2
Pancreatic Cancer Non-resectable · Pancreatic Cancer Non-resectable
26 / 57 pages
구조모아 (StructureMoa)항암 chemical structure spider web
KRMediMoa한의학·한약재 임상·근거 데이터
다음 갱신 D-5 · 마지막 9월 2일 · 방문 669 / 71,744